GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » Cyclically Adjusted PB Ratio

Spago Nanomedical AB (OSTO:SPAGO) Cyclically Adjusted PB Ratio : 0.05 (As of Jun. 19, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB Cyclically Adjusted PB Ratio?

As of today (2024-06-19), Spago Nanomedical AB's current share price is kr0.306. Spago Nanomedical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was kr6.70. Spago Nanomedical AB's Cyclically Adjusted PB Ratio for today is 0.05.

The historical rank and industry rank for Spago Nanomedical AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSTO:SPAGO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.1   Max: 0.72
Current: 0.05

During the past years, Spago Nanomedical AB's highest Cyclically Adjusted PB Ratio was 0.72. The lowest was 0.03. And the median was 0.10.

OSTO:SPAGO's Cyclically Adjusted PB Ratio is ranked better than
92.71% of 658 companies
in the Biotechnology industry
Industry Median: 1.665 vs OSTO:SPAGO: 0.05

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Spago Nanomedical AB's adjusted book value per share data for the three months ended in Mar. 2024 was kr0.153. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr6.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Spago Nanomedical AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Spago Nanomedical AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Cyclically Adjusted PB Ratio Chart

Spago Nanomedical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.62 0.08 0.05

Spago Nanomedical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.08 0.05 0.05 0.04

Competitive Comparison of Spago Nanomedical AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Spago Nanomedical AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's Cyclically Adjusted PB Ratio falls into.



Spago Nanomedical AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Spago Nanomedical AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.306/6.7
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spago Nanomedical AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Spago Nanomedical AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.153/132.2054*132.2054
=0.153

Current CPI (Mar. 2024) = 132.2054.

Spago Nanomedical AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 7.793 100.432 10.258
201409 7.658 100.161 10.108
201412 7.389 100.225 9.747
201503 7.086 99.950 9.373
201506 6.806 99.995 8.998
201509 6.611 100.228 8.720
201512 7.089 100.276 9.346
201603 6.845 100.751 8.982
201606 7.186 101.019 9.404
201609 7.059 101.138 9.227
201612 6.886 102.022 8.923
201703 6.694 102.022 8.674
201706 6.480 102.752 8.337
201709 6.237 103.279 7.984
201712 6.707 103.793 8.543
201803 6.693 103.962 8.511
201806 6.496 104.875 8.189
201809 6.700 105.679 8.382
201812 6.523 105.912 8.142
201903 6.483 105.886 8.094
201906 6.289 106.742 7.789
201909 6.073 107.214 7.489
201912 5.839 107.766 7.163
202003 5.595 106.563 6.941
202006 5.016 107.498 6.169
202009 4.882 107.635 5.996
202012 4.744 108.296 5.791
202103 4.984 108.360 6.081
202106 4.718 108.928 5.726
202109 4.487 110.338 5.376
202112 4.228 112.486 4.969
202203 4.002 114.825 4.608
202206 4.941 118.384 5.518
202209 2.188 122.296 2.365
202212 2.071 126.365 2.167
202303 1.920 127.042 1.998
202306 1.838 129.407 1.878
202309 1.760 130.224 1.787
202312 0.219 131.912 0.219
202403 0.153 132.205 0.153

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Spago Nanomedical AB  (OSTO:SPAGO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Spago Nanomedical AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB (OSTO:SPAGO) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (OSTO:SPAGO) Headlines

No Headlines